Vakrilova L, Mladenova A, Slŭncheva B
Akush Ginekol (Sofiia). 1993;32(3):20-3.
A prospective study of some coagulation screening tests in newborns is performed having in mind to elucidate coagulation status in healthy term newborns and the necessity of vitamin K prophylaxis. Two groups of newborn babies are formed: the first includes 29 babies without vit. K prophylaxis, the second--30 newborns who receive 1 mg/kg i.m. vit. K on the first day after birth. All the newborns have their prothrombin time (PT) and partial prothrombin time (aPTT) measured in day first, fourth, and in a small number on the seventh day as well. Low PT (54%) and moderately prolonged PTT (44.37 sec) are found on the first day after birth. It is established that the coagulation status is normalized faster in newborns who have received vit. K prophylaxis--as soon as fourth day, while the group without vit. K--until the end on the first or the beginning of the second week. The conclusion is made that it is wise to use vit. K prophylaxis not only with premature, but also in risk term infants.
为阐明健康足月儿的凝血状态及维生素K预防的必要性,开展了一项关于新生儿某些凝血筛查试验的前瞻性研究。将新生儿分为两组:第一组包括29例未接受维生素K预防的婴儿,第二组为30例在出生后第一天接受1mg/kg肌肉注射维生素K的新生儿。所有新生儿均在出生第一天、第四天测量凝血酶原时间(PT)和部分凝血活酶时间(aPTT),少数新生儿在第七天也进行了测量。出生后第一天发现PT较低(54%),PTT中度延长(44.37秒)。结果表明,接受维生素K预防的新生儿凝血状态在第四天就开始更快地恢复正常,而未接受维生素K预防的组直到第一周结束或第二周开始才恢复正常。得出的结论是,不仅对早产儿,而且对有风险的足月儿使用维生素K预防都是明智的。